Literature DB >> 18798046

Candida bloodstream infections in hemodialysis recipients.

Vasilios Pyrgos1, Kathryn Ratanavanich, Nancy Donegan, Judith Veis, Thomas J Walsh, Shmuel Shoham.   

Abstract

Candidemia is a major cause of morbidity and mortality in patients undergoing hemodialysis but it has not been well defined in this patient population. We performed a retrospective case-control study to characterize the epidemiology, microbiology, and outcomes of hemodialysis-associated candidemia. All cases of candidemia at our institution were evaluated from 1 January 2000 until 1 September 2004. For each case, two non-candidemic dialysis patients served as controls. Among 350 cases of candidemia, 78 (22%) occurred in adult hemodialysis patients. Cases and controls were similar with respect to age, corticosteroid, antibiotics use, prevalence of diabetes mellitus, liver cirrhosis, surgical procedures, and cancer. Multivariate analysis found total parenteral nutrition (TPN) (19.5% vs. 1.3%; P<0.0001) and dialysis through a vascular catheter (74% vs. 46.8%; P=0.0001) to be independently associated with candidemia. Non-C.albicans Candida spp. particularly C. glabrata and C. krusei were more common in hemodialysis recipients than in candidemic patients not receiving hemodialysis (31% vs. 17% p = 0.009). In-hospital mortality was significantly elevated for candidemic vs. non-candidemic hemodialysis recipients (51.9% vs. 7.8%; P<0.0001). Candidemia in hemodialysis recipients is frequently caused by non-C. albicansCandida species, is associated with TPN and dialysis via a vascular catheter (vs. shunt or fistula) and carries a high mortality rate.

Entities:  

Mesh:

Year:  2009        PMID: 18798046      PMCID: PMC7185292          DOI: 10.1080/13693780802369332

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  39 in total

1.  Microbiol growth in lipid emulsions used in parenteral nutrition.

Authors:  M A Melly; H C Meng; W Schaffner
Journal:  Arch Surg       Date:  1975-12

2.  Risk factors for candidaemia in critically ill patients: a prospective surveillance study.

Authors:  Ricard Jordà-Marcos; Francisco Alvarez-Lerma; Maite Jurado; Mercedes Palomar; Juan Nolla-Salas; María A León; Cristóbal León
Journal:  Mycoses       Date:  2007-07       Impact factor: 4.377

3.  Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.

Authors:  Michael Y Lin; Yehuda Carmeli; Jennifer Zumsteg; Ernesto L Flores; Jocelyn Tolentino; Pranavi Sreeramoju; Stephen G Weber
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; John H Rex
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

5.  Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

Authors:  L Saiman; E Ludington; M Pfaller; S Rangel-Frausto; R T Wiblin; J Dawson; H M Blumberg; J E Patterson; M Rinaldi; J E Edwards; R P Wenzel; W Jarvis
Journal:  Pediatr Infect Dis J       Date:  2000-04       Impact factor: 2.129

6.  Risk factors for hospital-acquired candidemia. A matched case-control study.

Authors:  S B Wey; M Mori; M A Pfaller; R F Woolson; R P Wenzel
Journal:  Arch Intern Med       Date:  1989-10

7.  Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases.

Authors:  E H Kossoff; E S Buescher; M G Karlowicz
Journal:  Pediatr Infect Dis J       Date:  1998-06       Impact factor: 2.129

8.  International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; R J Hollis; S A Messer
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

9.  Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy.

Authors:  T J Walsh; C Gonzalez; E Roilides; B U Mueller; N Ali; L L Lewis; T O Whitcomb; D J Marshall; P A Pizzo
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

10.  Transport of uremic toxins through conventional hemodialysis membranes.

Authors:  S Jörstad; L C Smeby; T E Wideröe; K J Berg
Journal:  Clin Nephrol       Date:  1979-10       Impact factor: 0.975

View more
  9 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease.

Authors:  Chetan V Jawale; Kritika Ramani; De-Dong Li; Bianca M Coleman; Rohan S Oberoi; Saran Kupul; Li Lin; Jigar V Desai; Greg M Delgoffe; Michail S Lionakis; Filitsa H Bender; Alexander J Prokopienko; Thomas D Nolin; Sarah L Gaffen; Partha S Biswas
Journal:  Sci Transl Med       Date:  2020-06-17       Impact factor: 17.956

3.  Black yeasts-like fungi isolated from dialysis water in hemodialysis units.

Authors:  Izabel Cristina Figel; Paulo Roberto Dantas Marangoni; Sabina Moser Tralamazza; Vânia Aparecida Vicente; Patrícia do Rocio Dalzoto; Mariana Machado Fidelis do Nascimento; G Sybren de Hoog; Ida Chapaval Pimentel
Journal:  Mycopathologia       Date:  2013-03-07       Impact factor: 2.574

4.  Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl.

Authors:  Amy R Biermann; Deborah A Hogan
Journal:  mSphere       Date:  2022-04-27       Impact factor: 5.029

5.  The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study.

Authors:  Hao Wang; Naizheng Liu; Mei Yin; Hui Han; Jinfeng Yue; Fan Zhang; Tichao Shan; Haipeng Guo; Dawei Wu
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

6.  A rare complication of a hemodialysis tunneled catheter: Case report of a superior vena cava and right atrium candida endocarditis.

Authors:  Mariana Sousa; Joana Martins; Sara Barreto; Cristina Santos; Rita Gouveia; José Paulo Santos; Nuno Guerra; Aura Ramos
Journal:  IDCases       Date:  2020-04-17

Review 7.  Candida Endocarditis: A Review of the Pathogenesis, Morphology, Risk Factors, and Management of an Emerging and Serious Condition.

Authors:  Sahil Mamtani; Nawar Muneer Aljanabi; Robins P Gupta Rauniyar; Ashu Acharya; Bilal Haider Malik
Journal:  Cureus       Date:  2020-01-18

8.  Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis.

Authors:  Daniel O Thomas-Rüddel; Peter Schlattmann; Mathias Pletz; Oliver Kurzai; Frank Bloos
Journal:  Chest       Date:  2021-10-18       Impact factor: 9.410

Review 9.  Diagnosis and Treatment of Invasive Candidiasis.

Authors:  Natalia Barantsevich; Elena Barantsevich
Journal:  Antibiotics (Basel)       Date:  2022-05-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.